Lacktman Quoted on DEA Telemedicine Registration to Treat Opioid Addiction
April 21, 2017
POLITICO Pro
Partner Nathaniel Lacktman was quoted in a POLITICO Pro article, “DOJ Slow to Help Opioid Epidemic with Telemedicine Change,” covering the failure of the Drug Enforcement Agency to enact a provision under the Ryan Haight Act, which allows for a special registry for doctors to treat opioid addicts through telemedicine.
Lacktman explained, “I think the DEA recognizes this need to navigate a balance of interests, and that’s why they are being thoughtful about it.” He then added that “the agency’s failure to issue the new guidelines means the government is only stopping legitimate providers, making it actually easier to buy illegal drugs over the Internet.”
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.